Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Market Capitalization (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Market Capitalization of $164.08 million for Q2 2026, down 7.4% from $177.24 million a year earlier and down 45.4% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Market Capitalization (2024 - 2026) Analysis & Trends

For FY2025, Nervgen Pharma posted Market Capitalization of $446.04 million, up 190.9% from FY2024.

  • By year, Market Capitalization came in at $153.33 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Market Capitalization since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Nervgen Pharma 105.93 Mn 4.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 164.08 Mn
Mar 31, 2026 300.28 Mn
Dec 31, 2025 446.04 Mn
Jun 30, 2025 177.24 Mn
Mar 31, 2025 140.67 Mn
Dec 31, 2024 153.33 Mn
API Access

Nervgen Pharma Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=NGEN&period=max&api_key=YOUR_API_KEY